{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:01:48Z","timestamp":1790730108463,"version":"4.1.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["22-09853S"],"award-info":[{"award-number":["22-09853S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union\u2019s Horizon Europe","award":["101087124"],"award-info":[{"award-number":["101087124"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Apolipoprotein E (ApoE) \u03b54 genotype is the most prevalent risk factor for late-onset Alzheimer\u2019s Disease (AD). Although ApoE4 differs from its non-pathological ApoE3 isoform only by the C112R mutation, the molecular mechanism of its proteinopathy is unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Here, we reveal the molecular mechanism of ApoE4 aggregation using a combination of experimental and computational techniques, including X-ray crystallography, site-directed mutagenesis, hydrogen-deuterium mass spectrometry (HDX-MS), static light scattering and molecular dynamics simulations. Treatment of ApoE \u03b53\/\u03b53 and \u03b54\/\u03b54 cerebral organoids with tramiprosate was used to compare the effect of tramiprosate on ApoE4 aggregation at the cellular level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found that C112R substitution in ApoE4 induces long-distance (&gt;\u200915 \u00c5) conformational changes leading to the formation of a V-shaped dimeric unit that is geometrically different and more aggregation-prone than the ApoE3 structure. AD drug candidate tramiprosate and its metabolite 3-sulfopropanoic acid induce ApoE3-like conformational behavior in ApoE4 and reduce its aggregation propensity. Analysis of ApoE \u03b54\/\u03b54 cerebral organoids treated with tramiprosate revealed its effect on cholesteryl esters, the storage products of excess cholesterol.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our results connect the ApoE4 structure with its aggregation propensity, providing a new druggable target for neurodegeneration and ageing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Graphic Abstract<\/jats:title><\/jats:sec>","DOI":"10.1186\/s13024-023-00620-9","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T19:09:07Z","timestamp":1686078547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer\u2019s Disease drug candidate"],"prefix":"10.1186","volume":"18","author":[{"given":"Michal","family":"Nemergut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio M.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Uhrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Vanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marketa","family":"Nezvedova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshak Chandulal","family":"Gadara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durga","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Novakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Planas-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonin","family":"Kunka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Hribkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Pospisilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Sedmik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Raska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbynek","family":"Prokop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Damborsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dasa","family":"Bohaciakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Spacil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Hernychova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bednar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7220-5644","authenticated-orcid":false,"given":"Martin","family":"Marek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"key":"620_CR1","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.2147\/NDT.S107969","volume":"12","author":"H Tomaskova","year":"2016","unstructured":"Tomaskova H, Kuhnova J, Cimler R, Dolezal O, Kuca K. Prediction of population with Alzheimer\u2019s disease in the European Union using a system dynamics model. Neuropsychiatr Dis Treat. 2016;12:1589\u201398.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"620_CR2","doi-asserted-by":"crossref","unstructured":"2022 Alzheimer\u2019s disease facts and figures. Alzheimers Dement J Alzheimers Assoc. 2022;18:700\u201389.","DOI":"10.1002\/alz.12638"},{"key":"620_CR3","doi-asserted-by":"publisher","unstructured":"Gustavsson A, Norton N, Fast T, Fr\u00f6lich L, Georges J, Holzapfel D et al. Global estimates on the number of persons across the Alzheimer\u2019s disease continuum. Alzheimers Dement [Internet]. [cited 2022 Jun 9];n\/a. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/alz.12694.","DOI":"10.1002\/alz.12694"},{"key":"620_CR4","doi-asserted-by":"crossref","first-page":"e12185","DOI":"10.1002\/trc2.12185","volume":"7","author":"J Cummings","year":"2021","unstructured":"Cummings J, Bauzon J, Lee G. Who funds Alzheimer\u2019s disease drug development? Alzheimers Dement Transl Res Clin Interv. 2021;7:e12185.","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"key":"620_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12929-019-0609-7","volume":"27","author":"L-K Huang","year":"2020","unstructured":"Huang L-K, Chao S-P, Hu C-J. Clinical trials of new drugs for Alzheimer disease. J Biomed Sci. 2020;27:18.","journal-title":"J Biomed Sci"},{"key":"620_CR6","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/alz.12213","volume":"17","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Jones DT, Greicius MD. Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019. Alzheimers Dement. 2021;17:696\u2013701.","journal-title":"Alzheimers Dement"},{"key":"620_CR7","doi-asserted-by":"crossref","first-page":"e12295","DOI":"10.1002\/trc2.12295","volume":"8","author":"J Cummings","year":"2022","unstructured":"Cummings J, Lee G, Nahed P, Kambar MEZN, Zhong K, Fonseca J, et al. Alzheimer\u2019s disease drug development pipeline: 2022. Alzheimers Dement Transl Res Clin Interv. 2022;8:e12295.","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"key":"620_CR8","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell. 2012;148:1204\u201322.","journal-title":"Cell"},{"key":"620_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40262-017-0608-3","volume":"57","author":"JA Hey","year":"2018","unstructured":"Hey JA, Yu JY, Versavel M, Abushakra S, Kocis P, Power A, et al. Clinical pharmacokinetics and safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the treatment of Alzheimer\u2019s Disease. Clin Pharmacokinet. 2018;57:315\u201333.","journal-title":"Clin Pharmacokinet"},{"key":"620_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.neurobiolaging.2006.02.015","volume":"28","author":"F Gervais","year":"2007","unstructured":"Gervais F, Paquette J, Morissette C, Krzywkowski P, Yu M, Azzi M, et al. Targeting soluble Abeta peptide with tramiprosate for the treatment of brain amyloidosis. Neurobiol Aging. 2007;28:537\u201347.","journal-title":"Neurobiol Aging"},{"key":"620_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s40263-017-0434-z","volume":"31","author":"P Kocis","year":"2017","unstructured":"Kocis P, Tolar M, Yu J, Sinko W, Ray S, Blennow K, et al. Elucidating the A\u03b242 anti-aggregation mechanism of action of Tramiprosate in Alzheimer\u2019s Disease: integrating Molecular Analytical Methods, pharmacokinetic and clinical data. CNS Drugs. 2017;31:495\u2013509.","journal-title":"CNS Drugs"},{"key":"620_CR12","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s40263-018-0554-0","volume":"32","author":"JA Hey","year":"2018","unstructured":"Hey JA, Kocis P, Hort J, Abushakra S, Power A, Vyhn\u00e1lek M, et al. Discovery and Identification of an endogenous metabolite of Tramiprosate and its Prodrug ALZ-801 that inhibits Beta amyloid oligomer formation in the human brain. CNS Drugs. 2018;32:849\u201361.","journal-title":"CNS Drugs"},{"key":"620_CR13","first-page":"219","volume":"3","author":"S Abushakra","year":"2016","unstructured":"Abushakra S, Porsteinsson A, Vellas B, Cummings J, Gauthier S, Hey JA, et al. Clinical benefits of Tramiprosate in Alzheimer\u2019s Disease Are Associated with higher number of APOE4 alleles: the \u201cAPOE4 gene-dose effect. J Prev Alzheimers Dis. 2016;3:219\u201328.","journal-title":"J Prev Alzheimers Dis"},{"key":"620_CR14","first-page":"149","volume":"4","author":"S Abushakra","year":"2017","unstructured":"Abushakra S, Porsteinsson A, Scheltens P, Sadowsky C, Vellas B, Cummings J, et al. Clinical Effects of Tramiprosate in APOE4\/4 homozygous patients with mild Alzheimer\u2019s Disease Suggest Disease Modification potential. J Prev Alzheimers Dis. 2017;4:149\u201356.","journal-title":"J Prev Alzheimers Dis"},{"key":"620_CR15","doi-asserted-by":"crossref","first-page":"e12117","DOI":"10.1002\/trc2.12117","volume":"6","author":"S Abushakra","year":"2020","unstructured":"Abushakra S, Porsteinsson AP, Sabbagh M, Bracoud L, Schaerer J, Power A, et al. APOE \u03b54\/\u03b54 homozygotes with early Alzheimer\u2019s disease show accelerated hippocampal atrophy and cortical thinning that correlates with cognitive decline. Alzheimers Dement N Y N. 2020;6:e12117.","journal-title":"Alzheimers Dement N Y N"},{"key":"620_CR16","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261:921\u20133.","journal-title":"Science"},{"key":"620_CR17","first-page":"321","volume":"17","author":"S Sadigh-Eteghad","year":"2012","unstructured":"Sadigh-Eteghad S, Talebi M, Farhoudi M. Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer`s disease. A meta-analysis. Neurosci Riyadh Saudi Arab. 2012;17:321\u20136.","journal-title":"Neurosci Riyadh Saudi Arab"},{"key":"620_CR18","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1038\/s41467-022-32183-6","volume":"13","author":"R Korologou-Linden","year":"2022","unstructured":"Korologou-Linden R, Bhatta L, Brumpton BM, Howe LD, Millard LAC, Kolaric K, et al. The causes and consequences of Alzheimer\u2019s disease: phenome-wide evidence from mendelian randomization. Nat Commun Nature Publishing Group. 2022;13:4726.","journal-title":"Nat Commun Nature Publishing Group"},{"key":"620_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1194\/jlr.R800069-JLR200","volume":"50","author":"RW Mahley","year":"2009","unstructured":"Mahley RW, Weisgraber KH, Huang Y, Apolipoprotein E. Structure determines function, from atherosclerosis to Alzheimer\u2019s disease to AIDS. J Lipid Res. 2009;50:183\u20138.","journal-title":"J Lipid Res"},{"key":"620_CR20","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2000;97:2892\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"620_CR21","doi-asserted-by":"publisher","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","volume":"110","author":"PB Verghese","year":"2013","unstructured":"Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, et al. ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions. Proc Natl Acad Sci U S A. 2013;110:E1807\u201316.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"620_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1146\/annurev.ne.19.030196.000413","volume":"19","author":"WJ Strittmatter","year":"1996","unstructured":"Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer\u2019s disease. Annu Rev Neurosci. 1996;19:53\u201377.","journal-title":"Annu Rev Neurosci"},{"key":"620_CR23","doi-asserted-by":"publisher","first-page":"9077","DOI":"10.1016\/S0021-9258(19)52510-8","volume":"256","author":"KH Weisgraber","year":"1981","unstructured":"Weisgraber KH, Rall SC, Mahley RW. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem. 1981;256:9077\u201383.","journal-title":"J Biol Chem"},{"key":"620_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12916-019-1299-4","volume":"17","author":"M Safieh","year":"2019","unstructured":"Safieh M, Korczyn AD, Michaelson DM. ApoE4: an emerging therapeutic target for Alzheimer\u2019s disease. BMC Med. 2019;17:64.","journal-title":"BMC Med"},{"key":"620_CR25","first-page":"1244","volume":"22","author":"A Yang","year":"2021","unstructured":"Yang A, Kantor B, Chiba-Falek OAPOE. The New Frontier in the development of a therapeutic target towards Precision Medicine in Late-Onset Alzheimer\u2019s. Int J Mol Sci Multidisciplinary Digital Publishing Institute. 2021;22:1244.","journal-title":"Int J Mol Sci Multidisciplinary Digital Publishing Institute"},{"key":"620_CR26","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1084\/jem.20121274","volume":"209","author":"J Kim","year":"2012","unstructured":"Kim J, Eltorai AEM, Jiang H, Liao F, Verghese PB, Kim J, et al. Anti-apoe immunotherapy inhibits amyloid accumulation in a transgenic mouse model of A\u03b2 amyloidosis. J Exp Med. 2012;209:2149\u201356.","journal-title":"J Exp Med"},{"key":"620_CR27","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","volume":"96","author":"T-PV Huynh","year":"2017","unstructured":"Huynh T-PV, Liao F, Francis CM, Robinson GO, Serrano JR, Jiang H, et al. Age-Dependent Effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis. Neuron. 2017;96:1013\u20131023e4.","journal-title":"Neuron"},{"key":"620_CR28","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1074\/jbc.M111.276162","volume":"287","author":"H-K Chen","year":"2012","unstructured":"Chen H-K, Liu Z, Meyer-Franke A, Brodbeck J, Miranda RD, McGuire JG, et al. Small molecule structure correctors abolish detrimental Effects of Apolipoprotein E4 in cultured neurons. J Biol Chem. 2012;287:5253\u201366.","journal-title":"J Biol Chem"},{"key":"620_CR29","first-page":"4120","volume":"62","author":"AM Petros","year":"2019","unstructured":"Petros AM, Korepanova A, Jakob CG, Qiu W, Panchal SC, Wang J, et al. Fragment-based Discovery of an apolipoprotein E4 (apoE4) stabilizer. J Med Chem American Chemical Society. 2019;62:4120\u201330.","journal-title":"J Med Chem American Chemical Society"},{"key":"620_CR30","doi-asserted-by":"publisher","first-page":"9533","DOI":"10.1021\/bi101407m","volume":"49","author":"K Garai","year":"2010","unstructured":"Garai K, Frieden C. The association \u2013 dissociation behavior of the ApoE proteins: kinetic and equilibrium studies. Biochemistry. 2010;49:9533\u201341.","journal-title":"Biochemistry"},{"key":"620_CR31","doi-asserted-by":"publisher","first-page":"10722","DOI":"10.1021\/bi700672v","volume":"46","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Vasudevan S, Sojitrawala R, Zhao W, Cui C, Xu C, et al. A monomeric, biologically active, full-length human apolipoprotein E. Biochemistry. 2007;46:10722\u201332.","journal-title":"Biochemistry"},{"key":"620_CR32","doi-asserted-by":"crossref","unstructured":"Chen J, Li Q, Wang J. Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc Natl Acad Sci. Proceedings of the National Academy of Sciences; 2011;108:14813\u20138.","DOI":"10.1073\/pnas.1106420108"},{"key":"620_CR33","doi-asserted-by":"publisher","first-page":"36758","DOI":"10.1074\/jbc.M005565200","volume":"275","author":"MA Perugini","year":"2000","unstructured":"Perugini MA, Schuck P, Howlett GJ. Self-association of human apolipoprotein E3 and E4 in the presence and absence of phospholipid. J Biol Chem. 2000;275:36758\u201365.","journal-title":"J Biol Chem"},{"key":"620_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1529\/biophysj.104.046813","volume":"88","author":"C-Y Chou","year":"2005","unstructured":"Chou C-Y, Lin Y-L, Huang Y-C, Sheu S-Y, Lin T-H, Tsay H-J, et al. Structural variation in human apolipoprotein E3 and E4: secondary structure, Tertiary structure, and size distribution. Biophys J. 2005;88:455\u201366.","journal-title":"Biophys J"},{"key":"620_CR35","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/1873-3468.13428","volume":"593","author":"E Hubin","year":"2019","unstructured":"Hubin E, Verghese PB, van Nuland N, Broersen K. Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation. FEBS Lett. 2019;593:1144\u201353.","journal-title":"FEBS Lett"},{"key":"620_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","volume":"541","author":"Y Namba","year":"1991","unstructured":"Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 1991;541:163\u20136.","journal-title":"Brain Res"},{"key":"620_CR37","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ajpath.2021.11.013","volume":"192","author":"J Gal","year":"2022","unstructured":"Gal J, Katsumata Y, Zhu H, Srinivasan S, Chen J, Johnson LA, et al. Apolipoprotein E proteinopathy is a Major Dementia-Associated Pathologic Biomarker in individuals with or without the APOE Epsilon 4 Allele. Am J Pathol Elsevier. 2022;192:564\u201378.","journal-title":"Am J Pathol Elsevier"},{"key":"620_CR38","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jmb.2006.06.080","volume":"361","author":"DM Hatters","year":"2006","unstructured":"Hatters DM, Zhong N, Rutenber E, Weisgraber KH. Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils. J Mol Biol. 2006;361:932\u201344.","journal-title":"J Mol Biol"},{"key":"620_CR39","first-page":"404","volume":"8","author":"G Sarkar","year":"1990","unstructured":"Sarkar G, Sommer SS. The \u201cmegaprimer\u201d method of site-directed mutagenesis. Biotechniques. 1990;8:404\u20137.","journal-title":"Biotechniques"},{"key":"620_CR40","first-page":"125","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch W. XDS. Acta Crystallogr D Biol Crystallogr. Int Union Crystallogr. 2010;66:125\u201332.","journal-title":"Int Union Crystallogr"},{"key":"620_CR41","first-page":"1204","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans PR, Murshudov GN. How good are my data and what is the resolution? Acta Crystallogr D Biol Crystallogr. Int Union Crystallogr. 2013;69:1204\u201314.","journal-title":"Int Union Crystallogr"},{"key":"620_CR42","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. J Appl Crystallogr International Union of Crystallography. 2007;40:658\u201374.","journal-title":"J Appl Crystallogr International Union of Crystallography"},{"key":"620_CR43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ymeth.2011.07.005","volume":"55","author":"P Adams","year":"2011","unstructured":"Adams P, Afonine P, Bunk\u00f3czi G, Chen V, Echols N, Headd J, et al. The Phenix Software for Automated determination of Macromolecular Structures. Methods San Diego Calif. 2011;55:94\u2013106.","journal-title":"Methods San Diego Calif"},{"key":"620_CR44","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr International Union of Crystallography. 2010;66:486\u2013501.","journal-title":"Acta Crystallogr D Biol Crystallogr International Union of Crystallography"},{"key":"620_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijms.2010.07.030","volume":"302","author":"D Kavan","year":"2011","unstructured":"Kavan D, Man P. MSTools\u2014Web based application for visualization and presentation of HXMS data. Int J Mass Spectrom. 2011;302:53\u20138.","journal-title":"Int J Mass Spectrom"},{"key":"620_CR46","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol Y, Csordas A, Bai J, Bernal-Llinares M, Hewapathirana S, Kundu DJ, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47:D442\u201350.","journal-title":"Nucleic Acids Res"},{"key":"620_CR47","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0006-3495(00)76713-0","volume":"78","author":"P Schuck","year":"2000","unstructured":"Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J. 2000;78:1606\u201319.","journal-title":"Biophys J"},{"key":"620_CR48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/bs.mie.2015.05.001","volume":"562","author":"CA Brautigam","year":"2015","unstructured":"Brautigam CA. Calculations and publication-quality illustrations for Analytical Ultracentrifugation Data. Methods Enzymol. 2015;562:109\u201333.","journal-title":"Methods Enzymol"},{"key":"620_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"MD Hanwell","year":"2012","unstructured":"Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminformatics. 2012;4:17.","journal-title":"J Cheminformatics"},{"key":"620_CR50","doi-asserted-by":"publisher","first-page":"10024","DOI":"10.1021\/ja00051a040","volume":"114","author":"AK Rappe","year":"1992","unstructured":"Rappe AK, Casewit CJ, Colwell KS, Goddard WA, Skiff WM. UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations. J Am Chem Soc. 1992;114:10024\u201335.","journal-title":"J Am Chem Soc"},{"key":"620_CR51","volume-title":"Gaussian 09, Revision E.01","author":"MJ Frisch","year":"2009","unstructured":"Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, et al. Gaussian 09, Revision E.01. Wallingford, CT: Gaussian, Inc.; 2009."},{"key":"620_CR52","unstructured":"Case DA, Babin V, Berryman JT, Betz RM, Cai Q, Cerutti S et al. AMBER 14. San Francisco: University of California; 2014."},{"key":"620_CR53","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/jcc.21816","volume":"32","author":"V Zoete","year":"2011","unstructured":"Zoete V, Cuendet MA, Grosdidier A, Michielin O. SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem. 2011;32:2359\u201368.","journal-title":"J Comput Chem"},{"key":"620_CR54","doi-asserted-by":"publisher","first-page":"D475","DOI":"10.1093\/nar\/gks1200","volume":"41","author":"PW Rose","year":"2013","unstructured":"Rose PW, Bi C, Bluhm WF, Christie CH, Dimitropoulos D, Dutta S, et al. The RCSB Protein Data Bank: new resources for research and education. Nucleic Acids Res. 2013;41:D475\u201382.","journal-title":"Nucleic Acids Res"},{"key":"620_CR55","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296\u2013303.","journal-title":"Nucleic Acids Res"},{"key":"620_CR56","doi-asserted-by":"publisher","unstructured":"Doerr S, Harvey MJ, No\u00e9 F, De Fabritiis GHTMD. High-Throughput Molecular Dynamics for Molecular Discovery. J Chem Theory Comput [Internet]. 2016 [cited 2016 Aug 30];12:1845\u201352. Available from: http:\/\/pubs.acs.org\/doi\/abs\/https:\/\/doi.org\/10.1021\/acs.jctc.6b00049.","DOI":"10.1021\/acs.jctc.6b00049"},{"key":"620_CR57","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/prot.22102","volume":"73","author":"DC Bas","year":"2008","unstructured":"Bas DC, Rogers DM, Jensen JH. Very fast prediction and rationalization of pKa values for protein\u2013ligand complexes. Proteins Struct Funct Bioinforma. 2008;73:765\u201383.","journal-title":"Proteins Struct Funct Bioinforma"},{"key":"620_CR58","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926\u201335.","journal-title":"J Chem Phys"},{"key":"620_CR59","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang J, Rauscher S, Nawrocki G, Ran T, Feig M, de Groot BL, et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods. 2017;14:71\u20133.","journal-title":"Nat Methods"},{"key":"620_CR60","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1073\/pnas.1705080114","volume":"114","author":"C Frieden","year":"2017","unstructured":"Frieden C, Wang H, Ho CMW. A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions. Proc Natl Acad Sci U S A. 2017;114:6292\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"620_CR61","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B","volume":"20","author":"K Feenstra","year":"1999","unstructured":"Feenstra K, Anton H, Berk, Berendsen Herman JC. Improving efficiency of large time-scale molecular dynamics simulations of hydrogen\u2010rich systems. J Comput Chem. 1999;20:786\u201398.","journal-title":"J Comput Chem"},{"key":"620_CR62","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1021\/ct900275y","volume":"5","author":"MJ Harvey","year":"2009","unstructured":"Harvey MJ, De Fabritiis G. An implementation of the smooth particle Mesh Ewald Method on GPU Hardware. J Chem Theory Comput. 2009;5:2371\u20137.","journal-title":"J Chem Theory Comput"},{"key":"620_CR63","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1021\/ct9000685","volume":"5","author":"MJ Harvey","year":"2009","unstructured":"Harvey MJ, Giupponi G, Fabritiis GD. ACEMD: accelerating Biomolecular Dynamics in the Microsecond Time Scale. J Chem Theory Comput. 2009;5:1632\u20139.","journal-title":"J Chem Theory Comput"},{"key":"620_CR64","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1021\/ct5010406","volume":"11","author":"CW Hopkins","year":"2015","unstructured":"Hopkins CW, Le Grand S, Walker RC, Roitberg AE. Long-time-step Molecular Dynamics through Hydrogen Mass Repartitioning. J Chem Theory Comput. 2015;11:1864\u201374.","journal-title":"J Chem Theory Comput"},{"key":"620_CR65","doi-asserted-by":"publisher","first-page":"065101","DOI":"10.1063\/1.3554380","volume":"134","author":"Y Naritomi","year":"2011","unstructured":"Naritomi Y, Fuchigami S. Slow dynamics in protein fluctuations revealed by time-structure based independent component analysis: the case of domain motions. J Chem Phys. 2011;134:065101.","journal-title":"J Chem Phys"},{"key":"620_CR66","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1021\/acs.jctc.6b00049","volume":"12","author":"S Doerr","year":"2016","unstructured":"Doerr S, Harvey MJ, No\u00e9 F, De Fabritiis GHTMD. High-throughput Molecular Dynamics for Molecular Discovery. J Chem Theory Comput. 2016;12:1845\u201352.","journal-title":"J Chem Theory Comput"},{"key":"620_CR67","unstructured":"Swails J. ParmEd [Internet]. 2010 [cited 2018 Mar 8]. Available from: https:\/\/github.com\/ParmEd\/ParmEd."},{"key":"620_CR68","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe DR, Cheatham TE. PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. J Chem Theory Comput. 2013;9:3084\u201395.","journal-title":"J Chem Theory Comput"},{"key":"620_CR69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1\u20132:19\u201325.","journal-title":"SoftwareX"},{"key":"620_CR70","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/bip.360221211","volume":"22","author":"W Kabsch","year":"1983","unstructured":"Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 1983;22:2577\u2013637.","journal-title":"Biopolymers"},{"key":"620_CR71","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/protein\/7.3.385","volume":"7","author":"J Aqvist","year":"1994","unstructured":"Aqvist J, Medina C, Samuelsson JE. A new method for predicting binding affinity in computer-aided drug design. Protein Eng. 1994;7:385\u201391.","journal-title":"Protein Eng"},{"key":"620_CR72","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BRI Miller","year":"2012","unstructured":"Miller BRI, McGee TDJr, Swails JM, Homeyer N, Gohlke H, Roitberg AE. MMPBSA.py: an efficient program for end-state Free Energy Calculations. J Chem Theory Comput American Chemical Society. 2012;8:3314\u201321.","journal-title":"J Chem Theory Comput American Chemical Society"},{"key":"620_CR73","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10:449\u201361.","journal-title":"Expert Opin Drug Discov"},{"key":"620_CR74","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A","volume":"20","author":"J Weiser","year":"1999","unstructured":"Weiser J, Shenkin PS, Still WC. Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO). J Comput Chem. 1999;20:217\u201330.","journal-title":"J Comput Chem"},{"key":"620_CR75","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"Y-T Lin","year":"2018","unstructured":"Lin Y-T, Seo J, Gao F, Feldman HM, Wen H-L, Penney J, et al. APOE4 causes widespread Molecular and Cellular alterations Associated with Alzheimer\u2019s Disease Phenotypes in Human iPSC-Derived brain cell types. Neuron. 2018;98:1141\u20131154e7.","journal-title":"Neuron"},{"key":"620_CR76","doi-asserted-by":"publisher","unstructured":"Fedorova V, Pospisilova V, Vanova T, Amruz Cerna K, Abaffy P, Sedmik J et al. Glioblastoma and cerebral organoids: development and analysis of an in vitro model for glioblastoma migration. Mol Oncol [Internet]. [cited 2023 Mar 14];n\/a. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/1878-0261.13389.","DOI":"10.1002\/1878-0261.13389"},{"key":"620_CR77","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1021\/acs.analchem.2c00981","volume":"95","author":"M Nezvedov\u00e1","year":"2023","unstructured":"Nezvedov\u00e1 M, Jha D, V\u00e1\u0148ov\u00e1 T, Gadara D, Kl\u00edmov\u00e1 H, Ra\u0161ka J, et al. Single cerebral organoid Mass Spectrometry of Cell-Specific protein and glycosphingolipid traits. Anal Chem American Chemical Society. 2023;95:3160\u20137.","journal-title":"Anal Chem American Chemical Society"},{"key":"620_CR78","doi-asserted-by":"publisher","first-page":"101563","DOI":"10.1016\/j.scr.2019.101563","volume":"40","author":"V Fedorova","year":"2019","unstructured":"Fedorova V, Vanova T, Elrefae L, Pospisil J, Petrasova M, Kolajova V, et al. Differentiation of neural rosettes from human pluripotent stem cells in vitro is sequentially regulated on a molecular level and accomplished by the mechanism reminiscent of secondary neurulation. Stem Cell Res. 2019;40:101563.","journal-title":"Stem Cell Res"},{"key":"620_CR79","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41398-019-0478-6","volume":"9","author":"AM Miranda","year":"2019","unstructured":"Miranda AM, Bravo FV, Chan RB, Sousa N, Di Paolo G, Oliveira TG. Differential lipid composition and regulation along the hippocampal longitudinal axis. Transl Psychiatry. 2019;9:144.","journal-title":"Transl Psychiatry"},{"key":"620_CR80","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.chembiol.2018.10.008","volume":"26","author":"K Huynh","year":"2019","unstructured":"Huynh K, Barlow CK, Jayawardana KS, Weir JM, Mellett NA, Cinel M, et al. High-throughput plasma lipidomics: detailed mapping of the Associations with Cardiometabolic Risk factors. Cell Chem Biol. 2019;26:71\u201384e4.","journal-title":"Cell Chem Biol"},{"key":"620_CR81","doi-asserted-by":"publisher","first-page":"7608","DOI":"10.1021\/acs.analchem.8b01331","volume":"90","author":"Q Xuan","year":"2018","unstructured":"Xuan Q, Hu C, Yu D, Wang L, Zhou Y, Zhao X, et al. Development of a high Coverage Pseudotargeted Lipidomics Method based on Ultra-High Performance Liquid Chromatography\u2013Mass Spectrometry. Anal Chem American Chemical Society. 2018;90:7608\u201316.","journal-title":"Anal Chem American Chemical Society"},{"key":"620_CR82","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1073\/pnas.1617523114","volume":"114","author":"PS Chetty","year":"2017","unstructured":"Chetty PS, Mayne L, Lund-Katz S, Englander SW, Phillips MC. Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry. Proc Natl Acad Sci Proceedings of the National Academy of Sciences. 2017;114:968\u201373.","journal-title":"Proc Natl Acad Sci Proceedings of the National Academy of Sciences"},{"key":"620_CR83","doi-asserted-by":"publisher","first-page":"110435","DOI":"10.1016\/j.celrep.2022.110435","volume":"38","author":"K Lindner","year":"2022","unstructured":"Lindner K, Beckenbauer K, van Ek LC, Titeca K, de Leeuw SM, Awwad K, et al. Isoform- and cell-state-specific lipidation of ApoE in astrocytes. Cell Rep. 2022;38:110435.","journal-title":"Cell Rep"},{"key":"620_CR84","doi-asserted-by":"publisher","first-page":"e494","DOI":"10.1038\/tp.2014.127","volume":"5","author":"P Proitsi","year":"2015","unstructured":"Proitsi P, Kim M, Whiley L, Pritchard M, Leung R, Soininen H, et al. Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer\u2019s disease. Transl Psychiatry. 2015;5:e494.","journal-title":"Transl Psychiatry"},{"key":"620_CR85","unstructured":"MahmoudianDehkordi S, Ahmed AT, Bhattacharyya S, Han X, Baillie RA, Arnold M et al. Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram\/escitalopram in major depression."},{"key":"620_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2018.00001","volume":"10","author":"P Bossu","year":"2018","unstructured":"Bossu P, Salani F, Ciaramella A, Sacchinelli E, Mosca A, Banaj N, et al. Anti-inflammatory Effects of Homotaurine in patients with amnestic mild cognitive impairment. Front Aging Neurosci Frontiers Media SA. 2018;10:1\u20138.","journal-title":"Front Aging Neurosci Frontiers Media SA"},{"key":"620_CR87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-5996-5-1","volume":"5","author":"EL Donovan","year":"2013","unstructured":"Donovan EL, Pettine SM, Hickey MS, Hamilton KL, Miller BF. Lipidomic analysis of human plasma reveals ether-linked lipids that are elevated in morbidly obese humans compared to lean. Diabetol Metab Syndr BioMed Central. 2013;5:1\u201313.","journal-title":"Diabetol Metab Syndr BioMed Central"},{"key":"620_CR88","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1523\/JNEUROSCI.2994-18.2019","volume":"39","author":"Y-WA Huang","year":"2019","unstructured":"Huang Y-WA, Zhou B, Nabet AM, Wernig M, S\u00fcdhof TC. Differential Signaling mediated by ApoE2, ApoE3, and ApoE4 in human neurons Parallels Alzheimer\u2019s Disease Risk. J Neurosci Society for Neuroscience. 2019;39:7408\u201327.","journal-title":"J Neurosci Society for Neuroscience"},{"key":"620_CR89","doi-asserted-by":"crossref","unstructured":"Berson A, Barbash S, Shaltiel G, Goll Y, Hanin G, Greenberg DS et al. Cholinergic-associated loss of hnRNP-A\/B in Alzheimer\u2019s disease impairs cortical splicing and cognitive function in mice. EMBO Mol Med. John Wiley & Sons, Ltd; 2012;4:730\u201342.","DOI":"10.1002\/emmm.201100995"},{"key":"620_CR90","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1007\/s12035-018-1237-z","volume":"56","author":"MdS Uddin","year":"2019","unstructured":"Uddin MdS, Kabir MdT, Al Mamun A, Abdel-Daim MM, Barreto GE, Ashraf GM. APOE and Alzheimer\u2019s Disease: evidence mounts that Targeting APOE4 may combat Alzheimer\u2019s pathogenesis. Mol Neurobiol. 2019;56:2450\u201365.","journal-title":"Mol Neurobiol"},{"key":"620_CR91","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","volume":"110","author":"YA Martens","year":"2022","unstructured":"Martens YA, Zhao N, Liu C-C, Kanekiyo T, Yang AJ, Goate AM, et al. ApoE Cascade Hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias. Neuron. 2022;110:1304\u201317.","journal-title":"Neuron"},{"key":"620_CR92","doi-asserted-by":"publisher","first-page":"13125","DOI":"10.1523\/JNEUROSCI.1937-12.2012","volume":"32","author":"NF Fitz","year":"2012","unstructured":"Fitz NF, Cronican AA, Saleem M, Fauq AH, Chapman R, Lefterov I, et al. Abca1 deficiency affects Alzheimer\u2019s disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice. J Neurosci Off J Soc Neurosci. 2012;32:13125\u201336.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"620_CR93","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1523\/JNEUROSCI.1400-19.2019","volume":"39","author":"V Rawat","year":"2019","unstructured":"Rawat V, Wang S, Sima J, Bar R, Liraz O, Gundimeda U, et al. ApoE4 alters ABCA1 membrane trafficking in astrocytes. J Neurosci Society for Neuroscience. 2019;39:9611\u201322.","journal-title":"J Neurosci Society for Neuroscience"},{"key":"620_CR94","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.3390\/ijms21176336","volume":"21","author":"MF Lanfranco","year":"2020","unstructured":"Lanfranco MF, Ng CA, Rebeck GW. ApoE lipidation as a therapeutic target in Alzheimer\u2019s Disease. Int J Mol Sci. 2020;21:6336.","journal-title":"Int J Mol Sci"},{"key":"620_CR95","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1172\/JCI96429","volume":"128","author":"F Liao","year":"2018","unstructured":"Liao F, Li A, Xiong M, Bien-Ly N, Jiang H, Zhang Y, et al. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J Clin Invest. 2018;128:2144\u201355.","journal-title":"J Clin Invest"},{"key":"620_CR96","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1073\/pnas.91.5.1834","volume":"91","author":"Y Huang","year":"1994","unstructured":"Huang Y, von Eckardstein A, Wu S, Maeda N, Assmann G. A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. Proc Natl Acad Sci U S A. 1994;91:1834\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"620_CR97","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1074\/jbc.273.10.5645","volume":"273","author":"JW Burgess","year":"1998","unstructured":"Burgess JW, Gould DR, Marcel YL. The HepG2 extracellular matrix contains separate heparinase- and lipid-releasable pools of ApoE. Implications for hepatic lipoprotein metabolism. J Biol Chem. 1998;273:5645\u201354.","journal-title":"J Biol Chem"},{"key":"620_CR98","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1074\/jbc.273.7.4206","volume":"273","author":"RB DeMattos","year":"1998","unstructured":"DeMattos RB, Curtiss LK, Williams DL. A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of Neurite Outgrowth in the absence of exogenous lipids or Lipoproteins*. J Biol Chem. 1998;273:4206\u201312.","journal-title":"J Biol Chem"},{"key":"620_CR99","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1021\/bi051765s","volume":"45","author":"MJ LaDu","year":"2006","unstructured":"LaDu MJ, Stine WB, Narita M, Getz GS, Reardon CA, Bu G. Self-assembly of HEK cell-secreted ApoE particles resembles ApoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein. Biochemistry. 2006;45:381\u201390.","journal-title":"Biochemistry"},{"key":"620_CR100","doi-asserted-by":"publisher","first-page":"43224","DOI":"10.1074\/jbc.M504513200","volume":"280","author":"R Koldamova","year":"2005","unstructured":"Koldamova R, Staufenbiel M, Lefterov I. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J Biol Chem. 2005;280:43224\u201335.","journal-title":"J Biol Chem"},{"key":"620_CR101","doi-asserted-by":"publisher","first-page":"43236","DOI":"10.1074\/jbc.M508780200","volume":"280","author":"SE Wahrle","year":"2005","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Hartman RE, Bales KR, Paul SM, et al. Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease. J Biol Chem. 2005;280:43236\u201342.","journal-title":"J Biol Chem"},{"key":"620_CR102","doi-asserted-by":"publisher","first-page":"22358","DOI":"10.1016\/S0021-9258(17)31797-0","volume":"269","author":"LM Dong","year":"1994","unstructured":"Dong LM, Wilson C, Wardell MR, Simmons T, Mahley RW, Weisgraber KH, et al. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem. 1994;269:22358\u201365.","journal-title":"J Biol Chem"},{"key":"620_CR103","doi-asserted-by":"publisher","first-page":"19053","DOI":"10.1074\/jbc.271.32.19053","volume":"271","author":"LM Dong","year":"1996","unstructured":"Dong LM, Weisgraber KH. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem. 1996;271:19053\u20137.","journal-title":"J Biol Chem"},{"key":"620_CR104","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1016\/j.bpj.2017.10.006","volume":"113","author":"A Ray","year":"2017","unstructured":"Ray A, Ahalawat N, Mondal J. Atomistic insights into structural differences between E3 and E4 isoforms of apolipoprotein E. Biophys J. 2017;113:2682\u201394.","journal-title":"Biophys J"},{"key":"620_CR105","doi-asserted-by":"publisher","first-page":"11657","DOI":"10.1021\/bi000099m","volume":"39","author":"JA Morrow","year":"2000","unstructured":"Morrow JA, Segall ML, Lund-Katz S, Phillips MC, Knapp M, Rupp B, et al. Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Biochemistry. 2000;39:11657\u201366.","journal-title":"Biochemistry"},{"key":"620_CR106","first-page":"9","volume":"1584","author":"P Acharya","year":"2002","unstructured":"Acharya P, Segall ML, Zaiou M, Morrow J, Weisgraber KH, Phillips MC, et al. Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism. Biochim Biophys Acta BBA - Mol Cell Biol Lipids. 2002;1584:9\u201319.","journal-title":"Biochim Biophys Acta BBA - Mol Cell Biol Lipids"},{"key":"620_CR107","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1016\/j.jmb.2019.04.019","volume":"431","author":"A-C Raulin","year":"2019","unstructured":"Raulin A-C, Kraft L, Al-Hilaly YK, Xue W-F, McGeehan JE, Atack JR, et al. The molecular basis for apolipoprotein E4 as the major risk factor for late-onset Alzheimer\u2019s Disease. J Mol Biol. 2019;431:2248\u201365.","journal-title":"J Mol Biol"},{"key":"620_CR108","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1021\/bi002417n","volume":"40","author":"J Dong","year":"2001","unstructured":"Dong J, Peters-Libeu CA, Weisgraber KH, Segelke BW, Rupp B, Capila I, et al. Interaction of the N-terminal domain of apolipoprotein E4 with heparin. Biochemistry. 2001;40:2826\u201334.","journal-title":"Biochemistry"},{"key":"620_CR109","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1110\/ps.9.5.886","volume":"9","author":"BW Segelke","year":"2000","unstructured":"Segelke BW, Forstner M, Knapp M, Trakhanov SD, Parkin S, Newhouse YM, et al. Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: implications for lipid binding. Protein Sci Publ Protein Soc. 2000;9:886\u201397.","journal-title":"Protein Sci Publ Protein Soc"},{"key":"620_CR110","doi-asserted-by":"publisher","first-page":"9273","DOI":"10.1021\/bi2010027","volume":"50","author":"RY-C Huang","year":"2011","unstructured":"Huang RY-C, Garai K, Frieden C, Gross ML. Hydrogen\/Deuterium exchange and Electron-transfer dissociation Mass Spectrometry Determine the Interface and Dynamics of Apolipoprotein E oligomerization. Biochemistry. 2011;50:9273\u201382.","journal-title":"Biochemistry"},{"key":"620_CR111","first-page":"8117","volume":"50","author":"B Gau","year":"2011","unstructured":"Gau B, Garai K, Frieden C, Gross ML. Mass Spectrometry-Based protein footprinting characterizes the Structures of Oligomeric Apolipoprotein E2, E3, and E4. Biochemistry. Am Chem Soc. 2011;50:8117\u201326.","journal-title":"Am Chem Soc"},{"key":"620_CR112","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/pro.2597","volume":"24","author":"C Frieden","year":"2015","unstructured":"Frieden C. ApoE: the role of conserved residues in defining function. Protein Sci Publ Protein Soc. 2015;24:138\u201344.","journal-title":"Protein Sci Publ Protein Soc"},{"key":"620_CR113","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1110\/ps.072851407","volume":"16","author":"H Yamada","year":"2007","unstructured":"Yamada H, Tamada T, Kosaka M, Miyata K, Fujiki S, Tano M, et al. Crystal lattice engineering,\u2019 an approach to engineer protein crystal contacts by creating intermolecular symmetry: crystallization and structure determination of a mutant human RNase 1 with a hydrophobic interface of leucines. Protein Sci Publ Protein Soc. 2007;16:1389\u201397.","journal-title":"Protein Sci Publ Protein Soc"},{"key":"620_CR114","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang C, Najm R, Xu Q, Jeong D-E, Walker D, Balestra ME, et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med. 2018;24:647\u201357.","journal-title":"Nat Med"},{"key":"620_CR115","unstructured":"Alzheon Inc. A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer\u2019s Disease and APOE4\/4 Genotype [Internet]. clinicaltrials.gov; 2022 Jun. Report No.: NCT04770220. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04770220."},{"key":"620_CR116","doi-asserted-by":"crossref","unstructured":"Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nat Nat Publishing Group; 2022;1\u201311.","DOI":"10.1038\/s41586-022-05439-w"},{"key":"620_CR117","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.stem.2018.12.013","volume":"24","author":"R van der Kant","year":"2019","unstructured":"van der Kant R, Langness VF, Herrera CM, Williams DA, Fong LK, Leestemaker Y, et al. Cholesterol metabolism is a Druggable Axis that independently regulates tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer\u2019s disease neurons. Cell Stem Cell. 2019;24:363\u2013375e9.","journal-title":"Cell Stem Cell"},{"key":"620_CR118","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","volume":"25","author":"C-C Liu","year":"2022","unstructured":"Liu C-C, Zhao J, Fu Y, Inoue Y, Ren Y, Chen Y, et al. Peripheral apoE4 enhances Alzheimer\u2019s pathology and impairs cognition by compromising cerebrovascular function. Nat Neurosci Nature Publishing Group. 2022;25:1020\u201333.","journal-title":"Nat Neurosci Nature Publishing Group"},{"key":"620_CR119","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu C-C, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15:501\u201318.","journal-title":"Nat Rev Neurol"},{"key":"620_CR120","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s43587-022-00190-3","volume":"2","author":"L Wang","year":"2022","unstructured":"Wang L, Dou Z. Apolipoprotein E regulates chromatin stability and senescence. Nat Aging Nature Publishing Group. 2022;2:282\u20134.","journal-title":"Nat Aging Nature Publishing Group"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-023-00620-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-023-00620-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-023-00620-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T19:00:22Z","timestamp":1702580422000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-023-00620-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":120,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1186\/s13024-023-00620-9","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"6 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Consent to participate"}},{"value":"All authors have approved of the consents of this manuscript and provided consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JD and ZP are founders of the biotechnology spin-off company Enantis Ltd. The company is not involved in R&D in the domain of Alzheimer\u2019s Disease.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}}],"article-number":"38"}}